Biological
Meningococcal pentavalent vaccine clinical trials
Keep track of what changes. Save the meningococcal pentavalent vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
7 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 1
Pfizer (3) · GlaxoSmithKline (2) · Novartis Vaccines (1) · Emory University (1)
Often tested with
Tested in the same studies.
4CMenB vaccine (5) · MenB-FHbp vaccine (3) · Meningococcal Vaccines (2)
Studies
Open first, then newest update. How each study uses meningococcal pentavalent vaccine is read from its arms, and is right about nine times in ten.
Testing it · 7
- MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young AdultsRecruitingPhase 4Emory UniversityNCT07197762Written as PENBRAYA
- A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy InfantsTerminatedPhase 2PfizerNCT04645966Written as MenABCWY
- A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.CompletedPhase 3PfizerNCT03135834Written as MenABCWY
- MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of AgeCompletedPhase 3PfizerNCT04440163Written as MenABCWY
- Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in AdolescentsCompletedPhase 2GlaxoSmithKlineNCT02946385Written as Meningococcal ABCWY Vaccine
- Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in AdolescentsCompletedPhase 2GlaxoSmithKlineNCT02212457Written as MenABCWY
- Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy AdolescentsCompletedPhase 2Novartis VaccinesNCT02140762Written as MenABCWY